GAD1 and cancer: Further analysis indicated that GAD1 mutations were concentrated in the T2 stage (T2a and T2c) and middle-prostate (Fig. 4B, C), and that they were associated with a late cancer diagnosis and higher fraction genome alteration (Fig. 4D, E).